Best time for hepatitis B vaccine after a stem cell transplant
Part of Digestive system, Infections clinical trials.
This study looks at the best time to give the hepatitis B vaccine after a stem cell transplant. It may help your body build protection against hepatitis B more effectively after your transplant.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 16 years old or older.
- You have had a stem cell transplant (also called a bone marrow transplant).
- Your blood tests show no signs of cancer (a complete molecular remission).
- You have not had a prior hepatitis B infection or positive test before or shortly after the transplant.
- You are not planning to have a second transplant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving the hepatitis B vaccine to full-term newborns who had multiple stomach or intestine surgeries is safe and works well. It aims to protect these babies from hepatitis B infection.
This study looks at people who had hepatitis B in the past (but are not currently infected) and are getting a stem cell transplant. The goal is to see if a simple model can predict whether the hepatitis B virus might come back, so doctors can monitor and treat it early.
This trial tests whether taking the antiviral medicine entecavir before and after a stem cell transplant can prevent hepatitis B from “waking up” again. It may help protect your liver during a high-risk treatment period.
This study looks at how your body's cells respond after getting a hepatitis B vaccine. It may help researchers understand how well the vaccine works.
This early-phase study tests whether a hepatitis B vaccine (with an added ingredient to boost the immune response) can safely help people with long-term hepatitis B who are already on antiviral therapy. It is mainly looking at safety and how the immune system responds.
This trial tests a vaccine that may help prevent diseases caused by the Epstein-Barr virus (EBV) after a stem cell transplant. It could lower the risk of infections and related complications.
Hear when a new Transplant-Related Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.